TITAN PHARMACEUTICALS INC (TTNP)

Titan pharmaceuticals notified of full compliance by NASDAQ (NASDAQ:TTNP)

Titan Pharmaceuticals, Inc. regains compliance with Nasdaq's bid price requirement, ensuring continued listing on The Nasdaq Capital Market.

Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria

SOUTH SAN FRANCISCO, Calif., Jan. 25, 2024 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) today announced that...

Titan Pharmaceuticals to conduct 1-for-20 reverse stock split (NASDAQ:TTNP)

Titan Pharmaceuticals announces a 1-for-20 reverse stock split, with split-adjusted shares expected to trade on Nasdaq in January.

Titan Pharmaceuticals Announces Reverse Stock Split and Ratio

SOUTH SAN FRANCISCO, Calif., Dec. 28, 2023 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) today announced that...

Titan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company's Board of Directors

SAN FRANCISCO, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (

Titan Pharmaceuticals Announces $9.5 Million Private Placement of Convertible Preferred Stock

SAN FRANCISCO, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

We're starting off the day with a breakdown of all the biggest pre-market stock movers traders need to know about on Friday!

Titan Pharmaceuticals Announces Sale of Certain ProNeura Assets

Company to receive $2 million in upfront payments, with the potential to receive up to $50 million in milestone payments and single digit royalty payments...

Titan Pharmaceuticals Provides Shareholder Update

Titan Pharmaceuticals Provides Shareholder Update

Signs Non-Binding Letter of Intent for Transformational TransactionContinues to Make Substantial Progress on Strategic Transactions Including Sale of...

UPDATE -- Titan Pharmaceuticals Inc. Announces Licensing Agreement with Ocular Therapeutix Inc.

UPDATE -- Titan Pharmaceuticals Inc. Announces Licensing Agreement with Ocular Therapeutix Inc.

SAN FRANCISCO, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that it has...

Titan Pharmaceuticals Announces Board Expansion and Management Changes

/PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that it has expanded its Board of Directors (the "Board")...